HeyJaredJoanne S. Eglovitch
- Indexed articles, last 90 days
- 13
- Latest publication
- Oct 1, 2026
- Outlet visibility, for Raps
- Top 1M sites
- Earliest in this view
- Aug 7, 2026
Latest articles
ICMRA joins call to replace animal testing with alternative approaches (opens the original)
Read excerpt
The US Department of Health and Human Services on Wednesday announced a program and funding opportunity through the Advanced Research Projects Agency for Health (ARPA-H) called the Simulation-augmented, Real-time Platform Adaptive Seamless Trials (SURPASS) program. The program aims to transform how clinical trials are designed and conducted to streamline them and ultimately bring products to market sooner.
FDA seeks feedback on framework for regulating GenAI devices (opens the original)
Read excerpt
Welcome to another installment of This Week at FDA, your weekly source for updates – big and small – on FDA, drug, and medical device regulation, and what we’re reading from around the web. This week, FDA said it wants to conduct research into perceived barriers to enrolling women in pregnancy exposure registries, the agency announced priority review voucher fees for the next fiscal year, and it named permanent leaders to three of its product centers.
Therapeutic equivalence: FDA finalizes guidance on TE evaluations (opens the original)
Read excerpt
Welcome to another installment of This Week at FDA, your weekly source for updates â big and small â on FDA, drug, and medical device regulation, and what weâre reading from around the web. This week, FDA said it wants to conduct research into perceived barriers to enrolling women in pregnancy exposure registries, the agency announced priority review voucher fees for the next fiscal year, and it named permanent leaders to three of its product centers.
FDA finalizes Q&A guidance on developing cell and gene therapies (opens the original)
Read excerpt
Welcome to another installment of This Week at FDA, your weekly source for updates – big and small – on FDA, drug, and medical device regulation, and what we’re reading from around the web. This week, FDA said it wants to conduct research into perceived barriers to enrolling women in pregnancy exposure registries, the agency announced priority review voucher fees for the next fiscal year, and it named permanent leaders to three of its product centers.
Trump taps Heidi Overton as next FDA Commissioner (opens the original)
Read excerpt
Welcome to another installment of This Week at FDA, your weekly source for updates – big and small – on FDA, drug, and medical device regulation, and what we’re reading from around the web. This week, FDA said it wants to conduct research into perceived barriers to enrolling women in pregnancy exposure registries, the agency announced priority review voucher fees for the next fiscal year, and it named permanent leaders to three of its product centers.
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
Top 1M sites
For Raps, the outlet · Measured Aug 1, 2026
Website popularity band, not a count of readers or article views.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.